NetworkNewsBreaks

MondayApr 20, 2020 12:10 pm

NetworkNewsBreaks – Dyadic International Inc. (NASDAQ: DYAI) Featured in Dawson James Securities Research Report

Dyadic International Inc. (NASDAQ: DYAI) was featured in a recent equity research report published by Dawson James Securities Inc. The report reads, “Once a vaccine is developed and tested, proved to be safe and effective, the next issue will be Scale. The ability to make not millions, but potentially billions of doses. We believe that the C1 platform could find utility in a COVID19 vaccine. Critical will be incorporating it early, into any vaccine’s development. The IIBR (Israel), ZAPI and UfoVax (Scripps spin out) consortium's may be working on a vaccine leveraging the C1 platform.” To request access to the…

Continue Reading

MondayApr 20, 2020 12:02 pm

NetworkNewsBreaks – Reed’s Inc. (NASDAQ: REED) Featured in ROTH Equity Research Report

Reed's Inc. (NASDAQ: REED) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “We raise 1Q20 estimates and reiterate our Buy. Reed’s Ginger Ale launch is showing strong initial acceptance, offering significant stock/estimate upside optionality. Simultaneously, both core brands, Reed’s and Virgil’s, are outperforming our growth assumptions. 1Q19 released preliminary results are ahead of consensus expectations and REED’s full-year guidance reiteration showcases solid visibility/confidence despite a volatile consumer environment.” To request access to the full report, visit http://nnw.fm/DXCr3 About Reed's Inc. Established in 1989, Reed's is America's best-selling Ginger Beer brand and…

Continue Reading

MondayApr 20, 2020 10:05 am

NetworkNewsBreaks – Gold Standard Ventures Corp. (TSX: GSV) (NYSE: GSV) Establishes At-The-Market “ATM” Equity Program

Gold Standard Ventures (TSX: GSV) (NYSE: GSV) today announced its entry into an Equity Distribution Agreement with BMO Capital Markets to establish an at-the-market equity program (the “ATM Program”). According to the update, the Company intends to issue up to CDN$14,875,000 of common shares (“Common Shares”) under the ATM Program. At the Company’s discretion, the Common Shares will be issued from treasury to the public from time to time. Under the ATM Program, any Common Shares will be sold at the prevailing market price at the time of sale, when sold through the NYSE American LLC (“NYSE American”) or any…

Continue Reading

MondayApr 20, 2020 9:42 am

NetworkNewsBreaks – Cannabis Global, Inc. (MCTC) Offers Hemp You Can Feel(TM) Discounts for 420 – Traditional Cannabis Culture Celebration Day

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced special online discount codes for purchases of Hemp You Can Feel(TM) Coffee on April 20 - the traditional cannabis culture celebration day. According to the update, purchases of all products using code ALLUNITED will yield 25% off all products at the www.HempYouCanFeel.com website. "This is a unique product line based on what we believe to be the most bioavailable infusion technologies in the marketplace,” Cannabis Global CEO Arman Tabatabaei stated in the news release. "The organic coffee is super-premium and sourced…

Continue Reading

FridayApr 17, 2020 3:07 pm

NetworkNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Provides Unique, Real-Time, Quality-Assurance Software

Sigma Labs (NASDAQ: SGLB) is leading the commercial 3D-metal-printing industry in providing invaluable quality-control technology throughout the metal-additive manufacturing space. An article discussing the company reads, “Sigma’s proprietary PrintRite3D(TM) is the first additive-manufacturing solution that enables real-time quality control, allowing errors to be detected and corrected in real time, thus saving both money and time. By providing the unique quality-assurance solution that the 3D-metal-printing sector needs, SGLB is set to leverage the latest additive-manufacturing research and processes to ensure the highest-quality, 3D-metal-printing results across a wide variety of sectors, including aerospace, automotive, biomedical and electronics.” To view the full article,…

Continue Reading

FridayApr 17, 2020 2:55 pm

NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Enabling Patients to Access Physicians from Home

Trxade Group’s (NASDAQ: MEDS) wholly owned subsidiary Bonum Health is a virtual telehealth provider that is helping patients to simply and affordably access board-certified physicians and receive medical prescriptions from the comfort of their homes. A recent article discussing the company reads, “On March 4, 2020, Congress approved an $8.3 billion package (http://nnw.fm/8qDeg) in emergency aid to combat the novel coronavirus, which included provisions for Medicare providers to administer telehealth services so that elderly patients, a particularly vulnerable demographic, could receive care at home. The aid package was summarily followed by a coalition of private health insurers, who after a…

Continue Reading

FridayApr 17, 2020 2:00 pm

NetworkNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Completes Landmark Shipment of Premium Medical Cannabis Products to Israel

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently completed a landmark shipment containing Supreme Cannabis’ premium medical cannabis product from Canada to Israel (http://nnw.fm/Ob7vr). An article discussing the company reads, “Supreme Cannabis interim president and CEO Colin Moore reported that the transaction, which was made possible through a partnership with Breath of Life International (BOL Pharma), represents a new international revenue opportunity for Supreme Cannabis and ‘builds Truverra’s global medical brand in one of the most sophisticated medical cannabis markets in the world.’ . . .‘With the support of BOL Pharma, we navigated both Canada and Israel’s complex…

Continue Reading

FridayApr 17, 2020 1:50 pm

NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Secures DTC Eligibility

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that its common shares are now fully eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”). Champignon’s common shares will continue to trade under the ticker symbol “SHRMF” on the OTC Markets. “We are actively engaged in pursuing new avenues of distribution both in North America and internationally, in order to enhance the ability of larger audiences to participate…

Continue Reading

FridayApr 17, 2020 1:20 pm

NetworkNewsBreaks – Evolus Inc. (NASDAQ: EOLS) Featured in Mizuho Securities Research Report

Evolus Inc. (NASDAQ: EOLS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Evolus announced a business update after the close as the aesthetics-focused company adjusts its cost structure and commercialization strategy in the face of the COVID-19 pandemic. With the majority of US aesthetics practices now closed or only seeing urgent cases, and the economic impact of the pandemic expected to significantly impact discretionary spending for several months, the company is reducing its headcount by >40%, temporarily reducing executive salaries and Board of Director fees, and delaying the European launch of…

Continue Reading

FridayApr 17, 2020 1:19 pm

NetworkNewsBreaks – Xeris Pharmaceuticals Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report

Xeris Pharmaceuticals Inc. (NASDAQ: XERS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We applied a weighted average valuation methodology (DCF+EV/Sales) to derive our $18PT. Our assumptions include: Launch of the glucagon rescue pen in the U.S. market in 4Q19, with peak-sales of $399 mil in 2029. DCF Assumptions: Terminal value of 4.0x 2029 FCF and 13% discount rate to derive a $20 PT. EV/Sales Assumptions: 4.0x multiple of 2025 sales, discounted at 13% to derive a $16 PT. Additional pipeline indications represent upside to our current price target.” To request…

Continue Reading